Continued Growth
The Erectile Dysfunction (ED) Market
The market is expected to continue its growth. The Americas is the largest market with North America larger than South America due to advanced technology and advanced medical facilities. This factor enables North America to emerge as the largest market on its own. All kinds of advanced medical facilities make North America an ideal market and hence, all kinds of drugs including erectile dysfunction drugs remain in demand.
- In 1998, the FDA approves Viagra® (sildenafil) for the treatment of ED
- Viagra’s massive success was practically instantaneous as first year sales yielded ~ US $1 Billion
- Cialis® and Levitra® are two other oral phosphodiesterase type 5 (PDE5) inhibitors that became available after Viagra®
- Over the past few decades, the utilization of PDE5 inhibitors in ED has propelled market revenue
- The global ED market is projected to grow from US $3.7 Billion in 2021 to US $5.9 Billion in 2028
There Are Many Unmet Needs in ED
Underdiagnosis
3 out of 4 men with ED do not seek
treatment due to inconvenience or slow-acting formulations.
Lack of Patient
Empowerment
There is significant stigma around
discussing ED and seeking treatment.
Minimal Patient Education
Patient awareness of ED and need for treatment is limited.
Effects of Food & Drink
Efficacy of the pill is diminished following ingestion of food and drink.
Limited Alternative-Delivery Strategies
No improvements to pill formulations have occurred in the past 2 decades and no non-pill alternative for patients with dysphagia.
No Spontaneity
Current ED treatments take up
to 1 hour for maximum efficacy.
Growing Demand
50% of men over 40 have some form of ED
Physical Causes
Neurogenic
High Blood Pressure
Kidney Disease
High Cholesterol
Hormonal Imbalance
Injury
Diabetes
BPH
Phychological Causes
Stress
Loss of Libido
Relationship Issues
Reliance on ED Treatment
Performance Anxiety
Depression